Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix

Gynecologic Oncology

Volumn 83, Issue 2, 2001, Pages 263-267

  Aoki, Yoichi ^a   Tomita, Masatosi ^a   Sato, Takaaki ^a   Watanabe, Minoru ^a   Kase, Hiroaki ^a   Fujita, Kazuyuki ^a   Kurata, Hitoshi ^a   Tanaka, Kenichi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Bulky tumor; Cervical squamous cell carcinoma; Cisplatin; Deep stromal invasion; Neoadjuvant chemotherapy; Vinblastin, and peplomycin; Younger patient

Indexed keywords

CARBON MONOXIDE; CISPLATIN; PEPLEOMYCIN; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGE; ALOPECIA; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HIGH RISK PATIENT; HUMAN; LEUKOPENIA; LUNG DIFFUSION CAPACITY; LYMPH NODE METASTASIS; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

EID: 0034766180     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6371     Document Type: Article

References (21)

1. Global cancer statistics
2. Local spread and lymph node involvement in cervical cancer
3. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix
4. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma
5. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix
6. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
7. Age and prognosis in stage Ib squamous cell carcinoma of the uterine cervix
8. Carcinoma of the cervix: The effect of age on survival
9. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group
10. Carcinoma of the cervix in the young patient
11. Carcinoma of the uterine cervix FIGO stage I-B
12. Histological criteria for the prognosis in patients with operated squamous cell carcinoma of the cervix
13. High-risk group in node-positive patients with stage IB, IIA, and IIb cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
14. Age as a prognostic factor in patients with squamous cell carcinoma of the uterine cervix
15. A possible new trend in the management of the carcinoma of the cervix uteri
16. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
17. Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer
18. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer
19. Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusion of cisplatin combined with 5 FU for locally advanced cervical adenocarcinoma
20. Cervical cancer response to neoadjuvant therapy: MR imaging assessment
21. Ovarian metastasis in stage IB and II cervical adenocarcinoma